Perrigo Company plc Business Combination, Contingent Consideration, Liability
Perrigo Company plc (PRGO) had Business Combination, Contingent Consideration, Liability of $0 as of 2015-09-15, per its 10-Q filed 2016-11-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2016-11-10
- 2015-09-15: Business Combination, Contingent Consideration, Liability $0.00.
- 2015-03-28: Business Combination, Contingent Consideration, Liability $12.40M.
- 2014-12-27: Business Combination, Contingent Consideration, Liability $12.40M.
- 2014-09-27: Business Combination, Contingent Consideration, Liability $12.40M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2015-09-15 | $0.00 10-Q · filed 2016-11-10 |
| 2015-03-28 | $12.40M 10-Q · filed 2015-04-29 |
| 2014-12-27 | $12.40M 10-Q · filed 2015-02-05 |
| 2014-09-27 | $12.40M 8-K · filed 2014-11-20 |
| 2014-06-28 | $17.40M 10-K · filed 2015-08-13 |
| 2013-06-29 | $22.20M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |